D.E. Shaw & Co
INVA icon

D.E. Shaw & Co’s Innoviva INVA Stock Holding History

D.E. Shaw & Co’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-60,000
Closed -$849K – 3803
2014
Q4 		$849K Hold
60,000
– – ﹤0.01% 2951
2014
Q3 		$1.02M Hold
60,000
– – ﹤0.01% 2791
2014
Q2 		$1.79M Sell
60,000
-14,460
-19% -$347K ﹤0.01% 2398
2014
Q1 		$1.86M Hold
74,460
– – ﹤0.01% 2461
2013
Q4 		$2.14M Hold
74,460
– – ﹤0.01% 2472
2013
Q3 		$2.45M Buy
74,460
+24,820
+50% +$772K ﹤0.01% 2244
2013
Q2 		$1.54M Buy
+49,640
New +$1.33M ﹤0.01% 2362

Other funds holding INVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co's INVA Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Innoviva (INVA) stake by 33% in Q1 2026, selling an estimated $2.64M and leaving 248,819 shares worth $5.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2067.

D.E. Shaw & Co first reported a position in INVA in Q3 2013 and has held it in 51 quarters since. The position peaked at $34.1M in Q4 2018. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • D.E. Shaw & Co held 248,819 shares of Innoviva worth $5.8M as of Q1 2026.
  • D.E. Shaw & Co sold 122,613 Innoviva shares in Q1 2026, an estimated $2.64M.
  • Innoviva made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2067 holding.
  • D.E. Shaw & Co first reported a position in Innoviva in Q3 2013 and has held it in 51 quarters since.
  • D.E. Shaw & Co's Innoviva position peaked at $34.1M in Q4 2018.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.